Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 1;53(3):e575-e589.
doi: 10.1097/CCM.0000000000006556. Epub 2025 Jan 6.

A Core Outcome Set for Adult General ICU Patients

Affiliations

A Core Outcome Set for Adult General ICU Patients

Maj-Brit Nørregaard Kjær et al. Crit Care Med. .

Abstract

Objectives: Randomized clinical trials informing clinical practice (e.g., like large, pragmatic, and late-phase trials) should ideally mostly use harmonized outcomes that are important to patients, family members, clinicians, and researchers. Core outcome sets for specific subsets of ICU patients exist, for example, respiratory failure, delirium, and COVID-19, but not for ICU patients in general. Accordingly, we aimed to develop a core outcome set for adult general ICU patients.

Design: We developed a core outcome set in Denmark following the Core Outcome Measures in Effectiveness Trials Handbook. We used a modified Delphi consensus process with multiple methods design, including literature review, survey, semi-structured interviews, and discussions with initially five Danish research panels. The core outcome set was internationally validated and revised based on feedback from research panels in all countries.

Setting: There were five Danish research panels and 17 panels in 13 other countries. Interviews and the three-round Delphi survey was conducted in Denmark, followed by validation of the core outcome set across 14 countries in Europe, Australasia, and India.

Subjects: Adult ICU survivors, family members, clinicians, and researchers.

Interventions: None.

Measurements and main results: We identified 329 published outcomes, of which 50 were included in the 264 participant Delphi survey. In semi-structured interviews of 82, no additional outcomes were added. The first Delphi survey round was completed by 249 (94%) participants, and 202 (82%) contributed to the third and final round. The initial core outcome set comprised six outcomes. International validation involved 217 research panel members and resulted in the final core outcome set comprising survival, free of life support, free of delirium, out of hospital, health-related quality of life, and cognitive function.

Conclusions: We developed and internationally validated a core outcome set with six core outcomes to be used in research, specifically clinical trials involving adult general ICU patients.

PubMed Disclaimer

Conflict of interest statement

Drs. Kjær’s and Granholm’s institutions received funding from Sygeforsikringen and the Novo Nordisk Foundation. Dr. Kjær’s institution received funding from the Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond, Savværksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat, and Dagmar Marshalls Fond; they received support for article research from the National Institutes of Health. Dr. Drnaholm’s institution received funding from the Independent Research Fund Denmark. Dr. Laerkner received funding from National Health and Medical Research Council (NHMRC) Investigator Fellowship (GNT2017081), The George Institute for Global Health, and the Fiona Stanley Hospital Intensive Care Unit; they received support for article research from Sygeforsikringen, the Novo Nordisk Foundation, Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond, Savværksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat, and Dagmar Marshalls Fond. Dr. Sivapalan received funding from Rigshospitalet, the Ehrenreich Foundation, Sygeforsikringen, the Novo Nordisk Foundation, Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond, Savværksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat, and Dagmar Marshalls Fond. Dr. Wise’s institution received funding from the National Institute of Health and Care Research National Institute for Health and Care Excellence (NICE) Rolling Call (health technology assessment programme). Dr. Hästbacka received funding from Paion. Dr. Litton received support for article research from the NHMRC Investigator Fellowship. Dr. Jha’s institution received funding from Astra Zeneca, Ousuka, and Visterra; he received funding from Visterra, Vera Therapeutics, Biocryst, Chinook, Alpine, GlaxoSmithKline (GSK), Astra Zeneca and Boehringer Ingelheim. Dr. Venkatesh received funding from the NHMRC Leadership Fellowship and Baxter. Dr. Collet’s institution received funding from Dagmar Marshall Fond. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Similar articles

Cited by

  • One-year outcomes in sepsis: a prospective multicenter cohort study in Japan.
    Liu K, Watanabe S, Nakamura K, Nakano H, Motoki M, Kamijo H, Ayaka M, Ishii K, Morita Y, Hongo T, Shimojo N, Tanaka Y, Hanazawa M, Hamagami T, Oike K, Kasugai D, Sakuda Y, Irie Y, Nitta M, Akieda K, Shimakura D, Katsukawa H, Kotani T, McWilliams D, Nydahl P, Schaller SJ, Ogura T; ILOSS Study Group. Liu K, et al. J Intensive Care. 2025 May 1;13(1):23. doi: 10.1186/s40560-025-00792-0. J Intensive Care. 2025. PMID: 40307943 Free PMC article.
  • INCEPT: The Intensive Care Platform Trial-Design and protocol.
    Granholm A, Møller MH, Kaas-Hansen BS, Jensen AKG, Munch MW, Kjær MN, Andersen LW, Schjørring OL, Rasmussen BS, Meyhoff TS, Larsen RF, Thorsen-Meyer HC, Collet MO, Meier NF, Estrup S, Mathiesen O, Maagaard M, Poulsen LM, Strøm T, Christensen S, Bruun CRL, Keus F, Rossing P, Granfeldt A, Brøchner AC, Itenov TS, Cronhjort M, Laake JH, Hästbacka J, Pfortmueller CA, Siegemund M, Sigurdsson MI, Andersen LPK, Placido D, Lange T, Perner A. Granholm A, et al. Acta Anaesthesiol Scand. 2025 Apr;69(4):e70023. doi: 10.1111/aas.70023. Acta Anaesthesiol Scand. 2025. PMID: 40084471 Free PMC article.
  • Effects of Continuous Versus Intermittent Glucose Monitoring in Intensive Care Unit Patients: Protocol for a Systematic Review With Meta-Analysis.
    Nielsen CG, Grigonyte-Daraskeviciene M, Blem MM, Kristensen PL, Pedersen-Bjergaard U, Olsen MT, Nørgaard K, Perner A, Mårtensson J, Møller MH, Bestle MH. Nielsen CG, et al. Acta Anaesthesiol Scand. 2025 Jul;69(6):e70086. doi: 10.1111/aas.70086. Acta Anaesthesiol Scand. 2025. PMID: 40548566 Free PMC article.

References

    1. Blackwood B, Marshall J, Rose L: Progress on core outcome sets for critical care research. Curr Opin Crit Care 2015; 21:439–444
    1. Møller MH: Patient-important outcomes and core outcome sets: Increased attention needed! Br J Anaesth 2019; 122:408–410
    1. Meyhoff TS, Hjortrup PB, Wetterslev J, et al.; CLASSIC Trial Group: Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med 2022; 386:2459–2470
    1. Kjær M-BN, Meyhoff TS, Sivapalan P, et al.: Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med 2023; 81:154737–154830
    1. Andersen-Ranberg NC, Poulsen LM, Perner A, et al.; AID-ICU Trial Group: Haloperidol for the treatment of delirium in ICU patients. N Engl J Med 2022; 387:2425–2435

LinkOut - more resources